Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: Retrospective cohort study (GENE-RAD-RISK)

BMJ (Online)

Volumn 345, Issue 7878, 2012, Pages

  Pijpe, Anouk ^a   Andrieu, Nadine ^b,c,d   Easton, Douglas F ^e   Kesminiene, Ausrele ^f   Cardis, Elisabeth ^g   Noguès, Catherine ^c   Gauthier Villars, Marion ^c   Lasset, Christine ^h   Fricker, Jean Pierre ⁱ   Peock, Susan ^e   Frost, Debra ^e   Evans, D Gareth ^j   Eeles, Rosalind A ^k   Clinical, Joan Paterson ^l   Manders, Peggy ^a,m   Van Asperen, Christi J ⁿ   Ausems, Margreet G E M ^o   Meijers Heijboer, Hanne ^p   Thierry Chef, Isabelle ^f   Hauptmann, Michael ^a   Goldgar, David ^q   Rookus, Matti A ^a   Van Leeuwen, Flora E ^a   more..

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b INSERM   (France)

^c INSTITUT CURIE   (France)

^d PSL RESEARCH UNIVERSITY   (France)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^g INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^h CENTRE LÉON BÉRARD   (France)

ⁱ CENTRE PAUL STRAUSS   (France)

^j ST MARY S HOSPITAL   (United Kingdom)

^k INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^l ADDENBROOKE S HOSPITAL   (United Kingdom)

^m RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁿ LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^o UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^p VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^q UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; FRANCE; GENE MUTATION; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NETHERLANDS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RADIOGRAPHY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SELF REPORT; SENSITIVITY ANALYSIS; UNITED KINGDOM; AGE; BREAST; BREAST TUMOR; GENETICS; MIDDLE AGED; MUTATION; PROPORTIONAL HAZARDS MODEL; RADIATION RESPONSE; RISK FACTOR; TUMOR SUPPRESSOR GENE;

ADULT; AGE FACTORS; BREAST; BREAST NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; GENES, BRCA1; GENES, BRCA2; HETEROZYGOTE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; MUTATION; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84867429638     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.e5660     Document Type: Article

References (40)

1. Ronckers CM, Erdmann CA, Land CE. Radiation and breast cancer: a review of current evidence. Breast Cancer Res 2005;7:21-32. (Pubitemid 40214533)
2. Powell SN, Kachnic LA. Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiation. Oncogene 2003;22:5784-91. (Pubitemid 37176700)
3. Venkitaraman AR. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 2002;108:171-82. (Pubitemid 34161138)
4. Yoshida K, Miki Y. Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage. Cancer Sci 2004;95:866-71. (Pubitemid 40045520)
5. Nieuwenhuis B, Van Assen-Bolt AJ, Van Waarde-Verhagen MA, Sijmons RH, Van der Hout AH, Bauch T, et al. BRCA1 and BRCA2 heterozygosity and repair of X-ray-induced DNA damage. Int J Radiat Biol 2002;78:285-95. (Pubitemid 34293348)
6. Boulton SJ. Cellular functions of the BRCA tumour-suppressor proteins. Biochem Soc Trans 2006;34:633-45. (Pubitemid 44796392)
7. Andrieu N, Easton DF, Chang-Claude J, Rookus MA, Brohey MR, Cardis E, et al. Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group. J Clin Oncol 2006;24:3361-6. (Pubitemid 46638890)
8. Gronwald J, Pijpe A, Byrski T, Huzarski T, Stawicka M, Cybulski C, et al. Early radiation exposures and BRCA1-associated breast cancer in young women from Poland. Breast Cancer Res Treat 2008;112:581-4.
9. Goldfrank D, Chuai S, Bernstein JL, Ramon Y, Cajal T, Lee JB, et al. Effect of mammography on breast cancer risk in women with mutations in BRCA1 or BRCA2. Cancer Epidemiol Biomarkers Prev 2006;15:2311-3.
10. Narod SA, Lubinski J, Ghadirian P, Lynch HT, Moller P, Foulkes WD, et al. Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Lancet Oncol 2006;7:402-6.
11. EMBRACE. http://ccge.medschl.cam.ac.uk/embrace.
12. Pijpe A, Manders P, Brohet RM, Collee JM, Verhoef S, Vasen HF, et al. Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers. Breast Cancer Res Treat 2010;120:235-44.
13. Antoniou AC, Goldgar DE, Andrieu N, Chang-Claude J, Brohet R, Rookus MA, et al. A weighted cohort approach for analysing factors modifying disease risks in carriers of high-risk susceptibility genes. Genet Epidemiol 2005;29:1-11. (Pubitemid 40911295)
14. Antoniou A, Pharoah PD, Narod S, Risch A, Eyfjord JE, Hopper JL, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003;72:1117-30. (Pubitemid 36530000)
15. Broeks A, Braaf LM, Wessels LF, van de Vijver M, De Bruin ML, Stovall M, et al. Radiation-associated breast tumors display a distinct gene expression profile. Int J Radiat Oncol Biol Phys 2010;76:540-7.
16. Langholz B, Richardson DB. Fitting general relative risk models for survival time and matched case-control analysis. Am J Epidemiol 2010;171:377-83.
17. Preston DL, Mattsson A, Holmberg E, Shore R, Hildreth NG, Boice JD Jr. Radiation effects on breast cancer risk: a pooled analysis of eight cohorts. Radiat Res 2002;158:220-35. (Pubitemid 34851818)
18. Land CE, Tokunaga M, Koyama K, Soda M, Preston DL, Nishimori I, et al. Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1990. Radiat Res 2003;160:707-17. (Pubitemid 37521714)
19. Land CE. Studies of cancer and radiation dose among atomic bomb survivors. The example of breast cancer. JAMA 1995;274:402-7.
20. Pijpe A, Manders P, Mulder RL, van Leeuwen FE, Rookus MA. Reliability of self-reported diagnostic radiation history in BRCA1/2 mutation carriers. Eur J Epidemiol 2010;25:103-13.
21. Pijpe A, Mulder RL, Manders P, van Leeuwen FE, Rookus MA. Validation study suggested no differential misclassification of self-reported mammography history in BRCA1/2 mutation carriers. J Clin Epidemiol 2011;64:1434-43.
22. Norman SA, Localio AR, Zhou L, Berstein L, Coates RJ, Flagg EW, et al. Validation of self-reported screening mammography histories among women with and without breast cancer. Am J Epidemiol 2003;158:264-71. (Pubitemid 36944420)
23. Pogoda JM, Preston-Martin S. Radiation exposure from diagnostic imaging: agreement between self-report and medical records. Health Phys 2002;83:907-17. (Pubitemid 35397071)
24. Berrington de Gonzalez A, Ekbom A, Glass AG, Galanti MR, Grimelius L, et al. Comparison of documented and recalled histories of exposure to diagnostic x-rays in case-control studies of thyroid cancer. Am J Epidemiol 2003;157:652-63. (Pubitemid 36368536)
25. Preston-Martin S, Bernstein L, Maldonado AA, Henderson BE, White SC. A dental x-ray validation study. Comparison of information from patient interviews and dental charts. Am J Epidemiol 1985;121:430-9. (Pubitemid 15128178)
26. Sickenga FN. Short history of the tuberculosis suppression in the Netherlands 1900-1960 [in Dutch]. KNCV Tuberculosisfoundation, 1980.
27. Sigurdson AJ, Bhatti P, Doody MM, Hauptmann M, Bowen L, Simon SL, et al. Polymorphisms in apoptosis- and proliferation-related genes, ionizing radiation exposure, and risk of breast cancer among US Radiologic Technologists. Cancer Epidemiol Biomarkers Prev 2007;16:2000-7. (Pubitemid 47621173)
28. International Commission of radiological protection (ICRP). Recommendations of the ICRP. Elsevier, 2007 (publication 103).
29. National Research Council. Health risks from exposure to low levels of ionizing radiation (BEIR VII). National Academy Press, 1999.
30. Mullenders L, Atkinson M, Paretzke H, Sabatier L, Bouffler S. Assessing cancer risks of low-dose radiation. Nat Rev Cancer 2009;9:596-604.
31. Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 2007;25:1329-33. (Pubitemid 46706879)
32. Sickenga FN. Observations on radiation hazards, with special reference to roentgen examinations of tuberculosis [in Dutch]. Ned Tijdschr Geneeskd 1959;103:1998-2005.
33. Drion R, Kiestra S, Peters A. Radiation dosage in fluoroscopy at a consultation office for tuberculosis control [in Dutch]. Ned Tijdschr Geneeskd 1961;105:1920-3.
34. Sickenga FN. Radiation dosage in fluoroscopy [in Dutch]. Ned Tijdschr Geneeskd 1961;105:2417-9.
35. Howe GR, McLaughlin J. Breast cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with breast cancer mortality in the atomic bomb survivors study. Radiat Res 1996;145:694-707.
36. Land CE. Low-dose radiation-a cause of breast cancer? Cancer 1980;46(4 suppl):868-73.
37. Eleveld H. Ionising radiation exposure in the Netherlands, RIVM report 861020002. 2003. www.rivm.nl/ims.
38. Meeuwsen EJ. Informatiesysteem Medische Stralingstoepassingen 2006, RIVM report 300081001 [in Dutch]. 2007. www.rivm.nl/ims.
39. Young KC, Burch A. Radiation doses received in the UK Breast Screening Programme in 1997 and 1998. Br J Radiol 2000;73:278-87. (Pubitemid 30192800)
40. Young KC, Burch A, Oduko JM. Radiation doses received in the UK Breast Screening Programme in 2001 and 2002. Br J Radiol 2005;78:207-18. (Pubitemid 40467642)